Objective: To review published literature on sclerema neonatorum (SN) in order to clarify its clinical presentation, histological features and management compared with two other diseases: subcutaneous fat necrosis of the newborn (SCFN) and scleredema.
Introduction
Sclerema neonatorum (SN) is classified under the Panniculitides, a group of heterogeneous inflammatory diseases involving the subcutaneous adipose tissue.
1,2 SN usually affects gravely ill, preterm neonates in the first week of life. [3] [4] [5] It manifests as a hardening of skin and subcutaneous adipose tissue to such an extent that it hinders feeding and respiration, and usually culminates in death.
Sclerema neonatorum was first described in the early nineteenth century, and initially was confused by some authorities with scleredema. In the early twentieth century, when cases of subcutaneous fat necrosis of the newborn (SCFN) were being reported, they were initially classified erroneously as SN, thus adding to the existing confusion in nomenclature. 3, [6] [7] [8] The last review on SN was published 20 years ago. 9 In this paper, we review the historical background of SN, its clinical presentation, histological features and the differentiating features from SCFN and scleredema. SN has a high case fatality rate, unlike the other two conditions, which makes timely diagnosis and treatment important.
Methodology
A search of the PubMed database using the key words, sclerema neonatorum, identified 180 articles. Those published in peerreviewed journals and in English language were included in the final review. Articles on SCFN and scleredema were also sought in the PubMed database using as search terms the names for these conditions, and were reviewed to inform the discussion of differential diagnoses. Snowballing technique was used to identify additional pertinent literature cited in the articles reviewed. The total number of articles on SN that were reviewed in detail and summarized was 55.
Results

History of nomenclature
Sclerema neonatorum was first described as 'acute sclerema' in 1718 ( Figure 1 ). Underwood presented a thorough description in 1784 and again in 1819 under another name, 'skin bound'. 3, [6] [7] [8] Meanwhile, in 1785, a French physician described a disease that he called 'Endurcissement du tissue cellulaire,' now known as scleredema; however, at that time it was considered the same as SN. 7, 8 The year 1815 saw the introduction of a new term, 'sclereme' for 'Endurcissement du tissue cellulaire'. The French regarded this condition as equivalent to skin bound, though Underwood was convinced that they were two different entities. [6] [7] [8] In 1877, a new term, 'oedema neonatorum' was introduced for 'Endurcissement du tissue cellulaire', and 'sclerema neonatorum' was used to refer to skin bound. 7, 8 This nomenclature was used until 1895, when it was noticed that SN was more commonly seen in France and Italy as compared to Great Britain, Germany, Austria, Russia, Spain, Switzerland and the United States. Based on the epidemiological data, Ballantyne, a British physician, argued erroneously that SN and 'oedema neonatorum' were the same disease. Subsequently, the term sclerema neonatorum was applied to both conditions, skin bound and 'oedema neonatorum'. 7, 8 Cases of SCFN were being reported since 1845 under the term 'Sclereme des adultes'. Fabyan described the histological picture of subcutaneous fat necrosis in 1907 whereas Bernheimer-Karrer called it 'benign sclerema' in 1922. 6 In 1926, both SN and SCFN were declared the same diseases. 7, 8 Thus, these three disorders of adipose tissues, SN, SCFN and scleredema have had multiple names applied to them and have been confused and labeled at times as a single disease with the interchangeable use of the term SN for all three conditions. Thus, the considerable confusion in the literature and the rarity of these conditions has hindered systematic descriptions of their features and pathogenesis and development of advances in management.
Since 1926, confusion has persisted in diagnosis of these three clinical entities that have different clinical and histological presentations. There has been confusion in these diseases as cases having mixed features of SN and SCFN, 6, 10, 11 and SN and scleredema have been reported. 12, 13 These cases have been published under the term of SN, thus adding more to the confusion, and will be discussed in detail under the section of differential diagnoses.
Clinical presentation
Sclerema neonatorum is seen in the first few days after birth but may develop immediately postpartum or as late as several weeks of life. The skin in affected neonates is smooth, cool, tense, mottled purplish and hard. The skin cannot be pitted nor can it be picked up and pinched into a fold as the skin is bound down to subjacent
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Histological features
The histological findings of sclerematous skin lesions show normal epidermis and dermis. The trabeculae forming the framework of the subcutaneous tissue are broadened and the fat spaces are diminished. There is a sparse inflammatory infiltrate without fat necrosis. Needle-shaped crystals are arranged radially in adipocytes. 2, 8, 16, 17 These crystals are formed from triglycerides of stearic and palmitic acids, which consist the neonatal subcutaneous fat. 18 Proks has called these A crystals. 18 He supports the idea that the excessive formation of A crystals, which are present in small amounts in the neonatal subcutaneous fat, results in SN, whereas they recrystallize as large B crystals in SCFN. 17 Horsfield and Yardley 10 have carried out X-ray diffraction on skin biopsy of a neonate affected with features of both SN and SCFN, and showed that the crystals in affected fat are larger than those found in normal subcutaneous fat, whereas Paysk 19 has supported the idea that their presence is nondiagnostic of 
Pathogenesis
Various theories on pathogenesis of SN have been proposed (Figure 2 ). The basis for Theory 1 is the observation that the composition of neonatal fat differs from adult fat in the presence of high amounts of saturated fatty acids such as stearic and palmitic acids, which causes a slight decrease in the content of unsaturated fatty acids such as oleic acid. Thus, neonatal fat has a relatively high melting point and a low solidification point that gives it a tendency to harden with falling body temperature. Hughes and Hammond support the idea that SN occurs under conditions of low peripheral body temperature as a consequence of circulatory collapse, for example, secondary to shock during an underlying grave illness. 14, 20 Arguing against this theory, however, is the observation that hardening of subcutaneous fat does not occur until temperatures below freezing point are reached and even then the texture of the hardened skin is quite unlike that of SN. 8 Theory 2 advances that thickening of the subcutaneous layer in the neonate with SN could be due to their decreased ability to mobilize fatty acids from subcutaneous adipose tissue due to either a defect in adipose lipolytic enzymes or in one of the lipid transport mechanisms. 14, 17 Normally, the level of free fatty acids in serum is low at birth and starts to rise within hours after birth due to rapid mobilization of fatty acids from adipose tissues. These are incorporated into triglycerides by the liver and supply metabolic energy and thus contribute toward maintaining body temperature of the neonate. Defective mobilization of these fatty acids from the adipose tissues may result in their thickening. 14, 17, 21 This also explains why most of the neonates affected by SN have difficulty maintaining body temperature.
Theory 3 pertains to SN being a sign of a grave underlying disorder. Warwick et al. 4 and Villacorte and Frank 3 contend that SN represents a sign of severe toxicity necessitating specific treatment of the underlying disease process. They base their hypothesis on the observation that death despite intensive care of infants with SN was always traceable to a specific disease or combination of diseases, whereas when their condition improved, it appeared in response to treatment of a diagnosed disease process. Kellum et al. 17 argue against this hypothesis by stating that many more infants sustain major systemic stresses like prematurity, dehydration, shock, chilling, surgical procedures and major infections without developing SN. Subcutaneous fat of neonates has a high ratio of saturated fatty acids which causes a slight decrease in unsaturated fatty acids. The saturated fat hardens due to a decrease in body temperature as a consequence of circulatory collapse due to shock. Elliott (1959) argues against this theory: Hardening of the subcutaneous fat does not occur until temperatures below freezing are reached and even then, the texture is quite unlike that of sclerema neonatorum. 
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Theory 4 purports that SN is a special form of edema affecting the connective tissue septa, 8 and thus accounts for the speed with which thickening of connective tissue septa sets in, 17 an observation that Theory 2, which contends that an inherent abnormality in adipocytes is responsible for the thickening, cannot explain. These theories have been summarized in Figure 2 .
Management
Local therapy or warming the body in an attempt to liquefy the saturated fatty acids has not proven to be beneficial.
14 Steroids have been used but have not improved survival, though their use has shown to limit spread of skin lesions of SN. 6, 15, 22, 23 Marks 24 has proposed steroids to be beneficial as adjunctive therapy while focusing on intensive therapy for sepsis and correction of fluid and electrolyte imbalance. Hughes and Hammond, 14 Warwick et al. 4 and Villacorte and Frank 3 have emphasized the importance of treating the underlying disease.
The outcome of SN with septicemia has been almost uniformly fatal even with the use of antibiotics and supportive therapy. The additional use of exchange transfusion (ET), however, has shown promising results in improving outcome of SN with culture-proven septicemia over the past three decades. One study of ET included only preterm infants 25 whereas others [26] [27] [28] [29] included both preterm and term infants. It was concluded that there is increased survival in neonates suffering from SN and sepsis when repeat ET is used early during the course of the disease. Sadana et al. 25 found greater improvement in survival after ET in the more premature group (28 to 32 week gestation) compared to those with gestational age >32 weeks. This can be attributed to the immunological components, including enhanced humoral and cellular immunity that are provided through ET to the immunologically immature neonates. ET also improves oxygen exchange by improving the peripheral and pulmonary circulation and shifting the oxygen dissociation curve to the right, and neutralizes endotoxins.
26-29
Differential diagnosis
There are two other diseases of the subcutaneous fat that are important in the differential diagnosis of SN. One of them is SCFN, which occurs in healthy infants, mostly post-term, within a few days to weeks after birth. It is characterized by sharply circumscribed areas of hardness that are attached to skin and move freely over muscle and bone. It develops over bony prominences on back, buttocks, thighs, shoulders, arms, neck and cheeks. Lesions have a nonpitting, wooden-to-stony consistency and the overlying skin may be discolored a reddish to a violescent hue. These lesions remain circumscribed, do not spread, disappear spontaneously over a period of months or turn cystic or calcify. [22] [23] [24] Asphyxia, mechanical and thermal trauma have been postulated in the pathogenesis of SCFN. Arguments that go against the view of trauma as an etiology of SCFN are that it has occurred in deliveries with no or minimal trauma. 24 Silverman 30 support the theory that an underlying biochemical defect in composition and metabolism of fat predisposes to this condition, whereas Elliott 8 support the view that it is not true fat necrosis but adipose cell necrosis due to trauma and local anoxemia. The histopathological findings show necrosis of subcutaneous adipocytes. There is an extensive inflammatory infiltrate consisting of lymphocytes, histiocytes, lipophages, multinucleate giant cells and eosinophils interspersed among the adipocytes of the fat lobule. Needle-shaped crystals are not only seen mainly in multinucleate giant cells but also in lipocytes. 2, 8, 16, 17, 24 These crystals are larger than those seen in SN and are arranged in rosettes. They are not diagnostic of SCFN as they have been found as post-mortem breakdown products and in lesions of BCG vaccination. 18 There have been reports of cases that have features of both, SN and SCFN. One such case was reported by Brain, 11 in which thickening of skin extending from the back of the neck to the lowest ribs occurred in a full-term neonate born as a result of an uneventful delivery. The process began on the third to fourth day of birth. The skin was a brownish red color with an irregular nodular surface. There were two soft fluctuating cysts in the lower part on each side of the midline. The skin of the affected area was normal in texture but firmly attached to the underlying subcutaneous tissue, which was indurated throughout the extent of the lesion. Histology of the affected skin showed the presence of a granulomatous infiltrate around the fat lobules. 11 The presence of fluctuating cysts with a granulomatous infiltrate point toward the diagnosis of SCFN but the extent of the skin lesions, induration of the skin and subcutaneous tissue are features of SN. This could be a case in which both conditions occur simultaneously.
Joncas 6 reported a similar case that presented features of both SN and SCFN. Horsfield and Yardley 10 have published a case report of a full-term baby with thickened skin on the trunk, chest wall and legs, and presence of hard discrete areas in the cheeks and buttocks. The baby had difficulty with sucking and swallowing and the condition resolved by the age of 5 months. The gestational age at birth, presence of hard discrete areas on the cheeks and buttocks, and the histological finding of granulomatous infiltrates surrounding the fat lobules in a biopsy specimen from an area on the buttocks point toward the diagnosis of SCFN, but the thickening of the skin on the trunk, chest wall and legs is characteristic of SN. These cases could be variants in which both SN and SCFN occurred simultaneously. Horsfield and Yardley 10 support the idea that SN and SCFN are different manifestations of the same underlying pathologic process whereas Marks 24 believe them to be two different clinical entities.
The other disease important for differential diagnosis of SN is scleredema, which occurs in premature infants and less frequently in term infants, usually in the first week of life. It is characterized by generalized firm, pitting edema, which is more common in lower extremities and manifests with an increase in the volume of the affected part. It is often preceded by cold injury, vomiting, diarrhea or other acute infection. Body temperature is usually subnormal and the infant is apathetic. 4, 24, 31, 32 Histopathology shows lobular panniculitis without vasculitis with an inflammatory infiltrate of lymphocytes and histiocytes in the fat lobules. There is marked edema in skin, subcutaneous tissue and sometimes underlying muscle. 2, 24, 32 This condition differs from scleredema adultorum, also known as scleredema adultorum of Buschke or acute sclerosis, which is a connective tissue disorder presenting in adults with brawny, hard, nonpitting skin that cannot be moved freely over underlying tissue, but can be compressed between thumb and finger to produce superficial ridges. It occurs in three types and is characterized by deposition of mucopolysaccharides in and around the collagen fibers in the dermis. 33 Some cases of scleredema have been published under the name of SN; consideration of these cases serves to illustrate important principles in distinguishing among them. Navarini-Meury et al. 13 recently reported a case under the name of SN that was caused by inducing whole-body hypothermia, 3 h after birth for 72 h, as a neuroprotective mechanism to prevent cerebral injury from birth asphyxia. The baby developed shell-like hardening of the skin of the back along with swelling that resolved in 2 months. This occurred in skin that was in contact with the water-filled mattress used for cooling. The shell-like hardening of skin points toward SN but it is not clear whether the authors meant edema when stating swelling, as its presence along with the causative factor of exposure to cold would favor a diagnosis of scleredema. It is not the lowering of the core temperature but the peripheral temperature that predisposes to development of SN. 14 Ghosal and Nag Chaudhuri 12 reported a case series of 15 infants who developed sclerematous skin lesions while suffering from diarrhea. The onset of lesions was within 3 months, all had diarrhea, most had vomiting and dehydration and two survived. The description of skin lesions fits SN but the presence of edema in eight infants does not. There was no histology available on skin lesions. Some or all of these cases could be scleredema. Such presentations have led to the speculation that scleredema is edema superimposed on SN. 24 Milunsky and Levin 34 have proposed that scleredema and SN are two different signs with a common pathogenesis. They argue that the major factor is the exposure to cold causing sluggish circulation and peripheral vasoconstriction, which contributes to the development of tissue anoxia and increased vascular permeability. If hypothermia is severe enough or prolonged, fluid from cellular and vascular spaces moves into the interstitial compartment, causing a sclerema-like feel of the skin and the subcutaneous tissues.
The above-stated cases demonstrate the confusion that exists in the differential diagnosis of SN with scleredema and SCFN. The differential diagnosis of SN with scleredema and SCFN along with the clinical presentation, histological findings, treatment and outcome has been summarized in Table 2 . 
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scleredema. In such cases, the histological features of the skin biopsy should be used for diagnosis as disease-specific treatment is imperative in SN due to high fatality. The presence of crystals in histological findings should not be used for diagnosing SN and SCFN; instead, the absence and presence of granulomatous infiltrate should be used, and the presence of edema favors a diagnosis of scleredema. An algorithm is presented in Figure 3 , which uses the clinical presentation and skin biopsy findings as guidance to correct diagnosis of these three clinical conditions.
